Exam #3 Flashcards
MS: diagnosis requires “dissemination in time and space”
- Space: evidence of scarring (plaques) in at least two separate areas of the CNS
- Time: evidence that the plaques occurred at different points in time
- Must be no other explanation
Fazekas scale
Measures white matter in brain for people with MS
Relapsing remitting
Most common, ups and downs
Secondary progressive
Develops over time, no remissions
Primary progressive
No eventual recovery, worsen
Progressive relapsing
No remission
Pathogenesis of MS (3)
- BBB: abnormally activated lymphocytes disrupt BBB
- Autoimmune: lymphocytes enter brain, activate local immune response
- Inflammation: t-cells attack on myelin and triggers inflammatory processes
Treatment of MS (5)
- Treatment of relapses
- Symptom management
- Disease modification
- Rehab
- Psychosocial support
What do disease-modifying drugs do for MS?
All reduce attack frequency and severity, reduce scarring on MRI, and probably slow disease progression
What does MS medications NOT do? (3)
- Cure the disease
- Make people feel better
- Alleviate symptoms
Where is seizure onset usually?
Left posterior medial temporal lobe
Ictal activity (during a seizure)
Stereotyped, driven behavior, not consciously controlled
Post-ictal activity (after a seizure)
Brain is “re-booting”, confusion, headache, fatigue
Inter-ictal (between seizures)
Ranges between normal and impaired, degree and type of dysfunction depends on location and severity of underlying abnormality
Treatment goal of epilepsy
Prevent start or spread of seizure activity